Quantum secret sharing between multiparty and multiparty with four states

An protocol of quantum secret sharing between multiparty and multiparty with four states is presented. We show that this protocol can make the Trojan horse attack with a multi-photon signal, the fake-signal attack with EPR pairs, the attack with single photons, and the attack with invisible photons to be nullification. In addition, we also give the upper bounds of the average success probabilities for dishonest agent eavesdropping encryption using the fake-signal attack with any two-particle entangled states.Comment: 7 page

Isolation of anticancer constituents from flos genkwa (Daphne genkwa Sieb.et Zucc.) through bioassay-guided procedures

BACKGROUND: Flos Genkwa (yuanhua in Chinese), the dried flower buds of Daphne genkwa Sieb.et Zucc. (Thymelaeaceae), is a traditional Chinese medicinal herb mainly used for diuretic, antitussive, expectorant, and anticancer effects. However, systematic and comprehensive studies on Flos Genkwa and its bioactivity are limited. RESULTS: After confirmation of the anti-tumor activity, the 95% ethanolic extract was subjected to successive solvent partitioning to petroleum ether, dichloromethane, n-butanol, and water soluble fractions. Each fraction was tested using the same biological activity model, and the dichloromethane fraction had the highest activity. The dichloromethane fraction was subjected to further chromatographic separation for the isolation of compounds 1–13. Among the 13 compounds, the diterpene esters (compounds 10–13) showed anticancer activity, whereas the flavonoids, lignanoids, and peptides showed moderate activity. Compound 13 was a new daphnane diterpenoid, which was named genkwanin VIII. The preliminary antitumor mechanism of yuanhuacine was studied by protein expression and cell cycle analysis in MCF-7 cancer cells. CONCLUSION: The present investigation tends to support the traditional use of Flos Genkwa for treating cancer. Through bioassay-guided fractionation and isolation techniques, the CH(2)Cl(2) fraction was determined as the active fraction of the flower buds of D. genkwa, and the anti-tumor activity was ascribable to the compounds 10–13

Mining Negative Temporal Contexts For False Positive Suppression In Real-Time Ultrasound Lesion Detection

During ultrasonic scanning processes, real-time lesion detection can assist radiologists in accurate cancer diagnosis. However, this essential task remains challenging and underexplored. General-purpose real-time object detection models can mistakenly report obvious false positives (FPs) when applied to ultrasound videos, potentially misleading junior radiologists. One key issue is their failure to utilize negative symptoms in previous frames, denoted as negative temporal contexts (NTC). To address this issue, we propose to extract contexts from previous frames, including NTC, with the guidance of inverse optical flow. By aggregating extracted contexts, we endow the model with the ability to suppress FPs by leveraging NTC. We call the resulting model UltraDet. The proposed UltraDet demonstrates significant improvement over previous state-of-the-arts and achieves real-time inference speed. To facilitate future research, we will release the code, checkpoints, and high-quality labels of the CVA-BUS dataset used in our experiments.Comment: 10 pages, 4 figures, MICCAI 2023 Early Accep

Information aggregation in a financial market with general signal structure

We study a financial market with asymmetric, multidimensional trader signals that have general correlation structure. Each of a continuum of traders belongs to one of finitely many “information groups.” There is a multidimensional aggregate signal for each group. Each trader observes an idiosyncratic signal about the fundamental, built from this group signal. Correlations across group signals are arbitrary. Several existing models serve as special cases, and new applications become possible. We establish existence and regularity of linear equilibrium, and demonstrate that the equilibrium price aggregates information perfectly as noise trade vanishes

Exploring hypotheses on karez initiation and decline in the Flaming Mountains from a photo modelling campaign

C

Quantum secret sharing between m-party and n-party with six states

We propose a quantum secret sharing scheme between $m$-party and $n$-party using three conjugate bases, i.e. six states. A sequence of single photons, each of which is prepared in one of the six states, is used directly to encode classical information in the quantum secret sharing process. In this scheme, each of all $m$ members in group 1 choose randomly their own secret key individually and independently, and then directly encode their respective secret information on the states of single photons via unitary operations, then the last one (the $m$th member of group 1) sends $1/n$ of the resulting qubits to each of group 2. By measuring their respective qubits, all members in group 2 share the secret information shared by all members in group 1. The secret message shared by group 1 and group 2 in such a way that neither subset of each group nor the union of a subset of group 1 and a subset of group 2 can extract the secret message, but each whole group (all the members of each group) can. The scheme is asymptotically 100% in efficiency. It makes the Trojan horse attack with a multi-photon signal, the fake-signal attack with EPR pairs, the attack with single photons, and the attack with invisible photons to be nullification. We show that it is secure and has an advantage over the one based on two conjugate bases. We also give the upper bounds of the average success probabilities for dishonest agent eavesdropping encryption using the fake-signal attack with any two-particle entangled states. This protocol is feasible with present-day technique.Comment: 7 page

Changing sources and burial of organic carbon in the Chukchi Sea sediments with retreating sea ice over recent centuries

Decreasing sea ice extent in summer caused by climate change is affecting the carbon cycle of the Arctic Ocean. In this study, surface sediments across the western Arctic Ocean are investigated to characterize sources of sedimentary organic carbon (OC). Bulk organic parameters (total organic carbon, total nitrogen, &delta;13Corg and &delta;15N) combined with molecular organic biomarkers (e.g., sterols and highly branched isoprenoids (HBIs)) are applied to distinguish between sympagic, pelagic, and terrestrial OC. Furthermore, downcore profiles of these parameters were also generated from the Chukchi Sea R1 core (74&deg; N) to evaluate changes in the relative contribution of these three components of sedimentary OC over the last 200 years with decreasing sea ice. Our data evidence that from 1820s to 1930s, prevailing high and variable sea ice cover inhibited in situ primary production resulting in prominent land-derived material stored in sediments. From 1930s to 1980s, with the gradual decline of sea ice, primary production increased progressively. The ratio of sympagic and pelagic OC began to rise to account for a larger portion of sedimentary OC. Since 1980s, accelerated sea ice loss led to enhanced primary production, stabilizing over the last decades due to freshwater induced surface ocean stratification in summer.</p

Application and research progress of antibody drug conjugates in HER2 positive advanced gastric cancer

Gastric cancer is a malignant tumor with high heterogeneity and invasiveness. Its incidence rate ranks fifth in the world, and its mortality ranks third in the world. Most patients are in a state that cancer cannot be removed by surgery when symptoms appear. At present, systemic treatment is the main treatment for advanced gastric cancer, and human epidermal growth factor receptor 2 (HER2) is one of the important treatment targets for HER2 positive gastric cancer patients. With the continuous optimization of chemotherapy regimen and targeted drugs, the prognosis of some HER2 positive gastric cancer patients has improved significantly. However, the high incidence of drug resistance and high toxicity and side effects are still the bottlenecks limiting the application of HER2 targeted drugs. Therefore, the development of new anti-tumor drugs is of great significance to improve the long-term survival of HER2 positive gastric cancer patients. Antibody drug conjugate (ADC) is a new and efficient anti-tumor drug, which is composed of specific targeted monoclonal antibody, chemical connector and small molecular cytotoxic payload. Its main advantages are strong therapeutic effect and moderate tissue toxicity. In recent years, ADC has set off a huge upsurge in the targeted treatment of HER2 positive advanced gastric cancer. First, after years of development, a variety of ADC including DS-8201 and RC48 have been used in the second- and second-line treatment of gastric cancer. Secondly, with the progress of ADC bioengineering technology, including high proportion of drug antibodies, cleavable linkers, toxic loads that can trigger bystander effect, the new type of ADC can play a more significant therapeutic role in the treatment of specific target tumors, and some of them also have multiple targets and can have anti-tumor effect on multiple specific targets. At the same time, the research and development process of ADC has reached the third stage. The new generation of ADC, through site-specific coupling technology, has higher homogeneity and uniformity, more effective cytotoxic molecules, higher accuracy and lower non-targeted toxicity. In addition, the "targeted immunotherapy" composed of ADC and immune checkpoint inhibitor (ICI) may be a promising treatment strategy for advanced gastric cancer. This article briefly reviewed the application and the latest research progress of ADC in HER2 positive advanced gastric cancer patients in the era of targeted therapy, and discussed the treatment prospects and challenges of ADC combined with ICI in HER2 positive advanced gastric cancer

Effect of GARP on osteogenic differentiation of bone marrow mesenchymal stem cells via the regulation of TGFβ1 in vitro

Mesenchymal stem cells (MSCs), which have multipotential differentiation and self-renewal potential, are possible cells for tissue engineering. Transforming growth factor β1 (TGFβ1) can be produced by MSCs in an inactive form, and the activation of TGFβ1 functions as an important regulator of osteogenic differentiation in MSCs. Recently, studies showed that Glycoprotein A repetitions predominant (GARP) participated in the activation of latent TGFβ1, but the interaction between GARP and TGFβ1 is still undefined. In our study, we successfully isolated the MSCs from bone marrow of rats, and showed that GARP was detected in bone mesenchymal stem cells (BMSCs). During the osteogenic differentiation of BMSCs, GARP expression was increased over time. To elucidate the interaction between GARP and TGFβ1, we downregulated GARP expression in BMSCs to examine the level of active TGFβ1. We then verified that the downregulation of GARP decreased the secretion of active TGFβ1. Furthermore, osteogenic differentiation experiments, alkaline phosphatase (ALP) activity analyses and Alizarin Red S staining experiments were performed to evaluate the osteogenic capacity. After the downregulation of GARP, ALP activity and Alizarin Red S staining significantly declined and the osteogenic indicators, ALP, Runx2, and OPN, also decreased, both at the mRNA and protein levels. These results demonstrated that downregulated GARP expression resulted in the reduction of TGFβ1 and the attenuation of osteoblast differentiation of BMSCs in vitro